Nociti, Viviana
 Distribuzione geografica
Continente #
NA - Nord America 4.376
EU - Europa 4.199
AS - Asia 3.047
SA - Sud America 699
AF - Africa 92
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.437
Nazione #
US - Stati Uniti d'America 4.283
DE - Germania 1.690
SG - Singapore 1.403
CN - Cina 874
SE - Svezia 751
BR - Brasile 579
UA - Ucraina 353
IT - Italia 293
FR - Francia 283
GB - Regno Unito 202
IE - Irlanda 168
IN - India 152
FI - Finlandia 150
VN - Vietnam 148
ID - Indonesia 119
RU - Federazione Russa 89
TR - Turchia 66
PL - Polonia 57
AR - Argentina 41
IQ - Iraq 40
JP - Giappone 40
CA - Canada 37
BE - Belgio 34
HK - Hong Kong 34
BD - Bangladesh 29
ZA - Sudafrica 29
AT - Austria 26
MX - Messico 25
NL - Olanda 22
IR - Iran 19
VE - Venezuela 17
CI - Costa d'Avorio 16
CO - Colombia 16
EC - Ecuador 16
KR - Corea 16
ES - Italia 15
MA - Marocco 15
SA - Arabia Saudita 15
UY - Uruguay 11
AU - Australia 10
AZ - Azerbaigian 9
IL - Israele 9
JO - Giordania 9
CH - Svizzera 8
CL - Cile 8
PK - Pakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
A2 - ???statistics.table.value.countryCode.A2??? 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
RO - Romania 6
TN - Tunisia 6
BG - Bulgaria 5
BY - Bielorussia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
NP - Nepal 5
DZ - Algeria 4
KZ - Kazakistan 4
LT - Lituania 4
MD - Moldavia 4
MY - Malesia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
HT - Haiti 3
HU - Ungheria 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
EE - Estonia 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TH - Thailandia 2
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
Totale 12.420
Città #
Chandler 758
Singapore 640
Ashburn 460
Jacksonville 248
Ann Arbor 191
San Mateo 178
Dublin 168
Beijing 163
Munich 159
New York 130
Los Angeles 116
Nürnberg 116
Nanjing 115
Jakarta 111
Wilmington 105
Dearborn 101
Hefei 91
Woodbridge 78
Houston 71
Boston 67
Princeton 62
Helsinki 58
Moscow 55
Marseille 50
Ho Chi Minh City 49
Hanoi 47
Milan 47
Seattle 46
Bremen 45
Buffalo 44
Izmir 44
Norwalk 43
Redwood City 43
Nanchang 41
São Paulo 41
Chicago 40
Dallas 40
Frankfurt am Main 35
Lawrence 35
Hong Kong 34
Brussels 33
Rome 33
Cattolica 32
Fairfield 29
Detroit 28
Warsaw 26
Kent 24
Kraków 24
Mountain View 24
Kunming 23
Shanghai 23
Hebei 22
University Park 22
Brooklyn 21
Rio de Janeiro 21
Shenyang 21
Tokyo 21
Boardman 20
Düsseldorf 20
Tianjin 20
Jiaxing 19
Nuremberg 19
Atlanta 18
Belo Horizonte 18
Johannesburg 18
Guangzhou 17
Santa Clara 17
Abidjan 16
Seoul 16
Fremont 15
Portsmouth 14
Turku 14
Baghdad 13
Chennai 13
Leawood 13
London 13
San Francisco 13
Stockholm 13
Vienna 13
Ottawa 12
Pune 12
Redmond 12
Zhengzhou 12
Changsha 11
Falls Church 11
Manchester 10
Amman 9
Baku 9
Denver 9
Hangzhou 9
Jinan 9
Bexley 8
Brasília 8
Fairport 8
Haiphong 8
Newark 8
North Bergen 8
Orem 8
Simi Valley 8
Toronto 8
Totale 5.941
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 248
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 238
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 226
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 226
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 207
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 206
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 197
Multiple Sclerosis attacks triggered by hyperprolactinemia 179
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 178
Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else? 178
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 168
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 168
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 162
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 161
Migraine-like headache and status migrainosus as attacks of Multiple Sclerosis in a child. 161
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 159
Pneumonia's link with the head and heart. 158
A Case of Hemiabdominal Myoclonus 157
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 154
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 153
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 150
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 150
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 149
Movement disorders in multiple sclerosis: Causal or coincidental association? 145
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 143
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 140
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 137
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 137
Type 1 immune response in progressive Multiple Sclerosis 135
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 134
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 133
Serum lactate as a novel potential biomarker in multiple sclerosis 130
Pneumonia's link with the head and the heart 126
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 125
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 124
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 122
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients 121
Breastfeeding and multiple sclerosis 121
Chronic migraine-like headache caused by a demyelinating lesion in the brainstem 121
Teaching NeuroImages: Autosomal dominant leukodystrophy in a sporadic case. 118
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 117
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 117
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 117
A Case of Hemiabdominal Myoclonus 115
Tourettism in multiple sclerosis: a case report 114
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 114
Coeliac disease presenting with acute disseminated encephalomyelitis 111
Case of postpartum Parsonage-Turner syndrome 110
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 109
Multiple sclerosis attacks triggered by hyperprolactinemia 108
Coeliac disease presenting with acute disseminated encephalomyelitis. 107
Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients 107
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 106
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 105
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 105
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 105
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 104
Glioblastoma in multiple sclerosis: a case report 104
Focal hyperhidrosis in tumefactive Multiple Sclerosis 103
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 102
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 101
Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection 101
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 101
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 99
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 99
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 99
A unique case of multiphasic ADEM or what else? 99
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 99
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 98
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 98
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 98
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 96
Posterior reversible encephalopathy syndrome after intramuscular oxygen-ozone therapy 96
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 95
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 95
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 94
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 90
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 89
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 89
Fingolimod vs dimethyl fumarate in multiple sclerosis 89
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 89
Clinical characteristics, course and prognosis of spinal multiple sclerosis 88
What do we know about the role of lncRNAs in multiple sclerosis? 88
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 87
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 87
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 86
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 84
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 84
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 82
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 79
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 78
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 78
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 78
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy 77
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 77
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 77
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 71
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 67
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 66
Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis 65
Totale 12.038
Categoria #
all - tutte 51.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021539 0 0 0 0 0 44 80 34 90 61 200 30
2021/2022959 98 78 18 120 29 38 17 141 48 55 130 187
2022/20232.007 224 283 164 319 121 276 101 183 233 31 53 19
2023/2024907 35 269 26 59 24 122 92 27 21 24 103 105
2024/20251.929 54 67 145 97 124 85 78 99 321 166 381 312
2025/20262.744 775 140 262 518 910 139 0 0 0 0 0 0
Totale 12.561